JPMORGAN CHASE & CO - 31 Mar 2025 SCHEDULE 13G/A Report for REGENERON PHARMACEUTICALS, INC. Common Stock - par value $.001 per share (REGN)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: REGENERON PHARMACEUTICALS, INC. Common Stock - par value $.001 per share
Symbol: REGN
Shares outstanding: 108,753,608 shares
Disclosed Ownership: 5,546,434 shares
Ownership: 5.1%
Form type: SCHEDULE 13G/A
Filing time: 22 Apr 2025, 12:01:04 UTC
Date of event: 31 Mar 2025
Next filing: 05 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	5.1%	5,546,434	4,877,261	30,735	Rachel Tsvaygoft	Vice President